Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Investing Activities (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Cash from Investing Activities for 16 consecutive years, with -$2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 16.36% year-over-year to -$2.1 million, compared with a TTM value of -$8.2 million through Dec 2025, up 6.35%, and an annual FY2025 reading of -$8.2 million, up 6.35% over the prior year.
  • Cash from Investing Activities was -$2.1 million for Q4 2025 at Cross Country Healthcare, up from -$2.2 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$1.1 million in Q3 2024 and bottomed at -$37.1 million in Q4 2022.
  • Average Cash from Investing Activities over 5 years is -$5.4 million, with a median of -$2.4 million recorded in 2024.
  • The sharpest move saw Cash from Investing Activities crashed 1620.29% in 2021, then soared 93.33% in 2022.
  • Year by year, Cash from Investing Activities stood at -$4.7 million in 2021, then tumbled by 691.95% to -$37.1 million in 2022, then soared by 92.25% to -$2.9 million in 2023, then rose by 11.97% to -$2.5 million in 2024, then rose by 16.36% to -$2.1 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CCRN at -$2.1 million in Q4 2025, -$2.2 million in Q3 2025, and -$2.0 million in Q2 2025.